Updated:
Aceras BioMedical
Aceras BioMedical is a private equity asset manager focused on early stage venture.
Aceras BioMedical
Aceras BioMedical is a healthcare investment firm focused on emerging biotechnology and medical device companies. It specializes in licensing, acquisition, and internal development of therapeutic products and medical devices through new company formations. The firm has made one investment, in Modis Therapeutics as part of their Series A on October 01, 2018, and one portfolio exit, Modis Therapeutics on August 26, 2019.
General information
Firm type
Private Equity
Year founded
—
AUM
Undisclosed
Location
Region
North America
Country
United States
City
New York
Corporate office
New York, United States
Sector focus
Frequently asked questions
What is Aceras BioMedical's investment strategy?
The firm targets early stage and venture general investments.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: